Technical Analysis for BCT - Briacell Therapeutics Corp.

Grade Last Price % Change Price Change
F 1.050 -2.78% -0.030
BCT closed down 2.78 percent on Friday, July 26, 2024, on 10 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -2.78%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.78%
MACD Bullish Signal Line Cross Bullish -2.78%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Briacell Therapeutics Corp. Description

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine

Is BCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.29
52 Week Low 0.84
Average Volume 15,612
200-Day Moving Average 4.273
50-Day Moving Average 1.628
20-Day Moving Average 1.236
10-Day Moving Average 1.107
Average True Range 0.136
RSI (14) 36.31
ADX 38.07
+DI 15.599
-DI 35.838
Chandelier Exit (Long, 3 ATRs) 1.134
Chandelier Exit (Short, 3 ATRs) 1.247
Upper Bollinger Bands 1.567
Lower Bollinger Band 0.906
Percent B (%b) 0.22
BandWidth 53.434
MACD Line -0.196
MACD Signal Line -0.207
MACD Histogram 0.011
Fundamentals Value
Market Cap 810.56 Thousand
Num Shares 772 Thousand
EPS -0.04
Price-to-Earnings (P/E) Ratio -27.63
Price-to-Sales 0.00
Price-to-Book 10.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.080
Resistance 3 (R3) 1.077 1.063 1.075
Resistance 2 (R2) 1.063 1.056 1.065 1.073
Resistance 1 (R1) 1.057 1.051 1.060 1.060 1.072
Pivot Point 1.043 1.043 1.045 1.045 1.043
Support 1 (S1) 1.037 1.036 1.040 1.040 1.028
Support 2 (S2) 1.023 1.031 1.025 1.027
Support 3 (S3) 1.017 1.023 1.025
Support 4 (S4) 1.020